Mitegen, XTalQuest Enter Mutual Distribution Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mitegen today announced a mutual distribution agreement with XTalQuest to promote and sell each other's products.

Under the deal, XTalQuest will promote and sell Mitegen's MicroMount, MicroLoop, MicroMesh, RT Aligner, and other products in China, Taiwan, and Singapore. Mitegen will promote and sell XTalQuest's line of crystallization plates, crystallization stock solutions, and other products in North and South America.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.